Relationship between metabolic syndrome and benign prostatic hyperplasia
10.3760/cma.j.issn.0254-9026.2011.11.004
- VernacularTitle:代谢综合征与良性前列腺增生的相关性研究
- Author:
Lin CHU
;
Yide MIAO
;
Lingxia CHEN
- Publication Type:Journal Article
- Keywords:
Prostatic hyperplasia;
Metabolic syndrome X
- From:
Chinese Journal of Geriatrics
2011;30(11):914-916
- CountryChina
- Language:Chinese
-
Abstract:
ObjectiveTo evaluate the relationship between metabolic syndrome (MS) and benign prostatic hyperplasia (BPH).MethodsTotally 101 male patients with MS and 117 male patients without MS were enrolled from September 2008 to January 2010 in the department of geriatrics of Peking University People's Hospital.The MS diagnosis was made according to the criteria by Chinese Diabetes Society (2004).Blood pressure,body weight,body height,body mass index (BMI) were measured and calculated.Biochemical analyses including serum fasting blood glucose (FBG),total cholesterol ( TC),triglycerides (TG),low-density lipoprotein cholesterol (LDL-C),high-density lipoprotein cholesterol (HDL-C),and prostate-specific antigen (PSA) were performed.Total prostate volume (PV) were measured by ultrasound.ResultsPV in patients with MS[(39.7±21.1)m1] was significantly larger than in patients without MS[(30.7±9.3)ml] (P＜ 0.05).There was no difference in PSA level between groups (P＞ 0.05).PV were positively correlated with BMI(r=0.27,P=0.019),hypertension duration(r=0.37,P=0.01),PSA(r=0.51,P=0.001),FBG(r=0.24,P=0.013) and systolic blood pressure(SBP)(r=0.20,P=0.047),but negatively correlated with HDL-C ( r = - 0.24,P = 0.013 ).Conclusions BMI,hypertension duration,PSA,FBG,SBP,and lower HDL-C may play roles in the pathogenesis of prostatic hvperplasia.
